Medtronic plc logo
Medtronic plc (MDT)
Compare

Medtronic plc (MDT) Free Cash Flow (FCF): $5.43B

The free cash flow (FCF) for Medtronic plc (MDT) is $5.43B. It is above its 12-month average by 2.27% ($5.31B).

MDT Free Cash Flow (FCF) Chart

MDT Free Cash Flow (FCF)
$5.43B+4.65% 1Y
Zoom

MDT Average Free Cash Flow (FCF) Chart

MDT Current vs Average Free Cash Flow (FCF) Chart

MDT Free Cash Flow (FCF) Metrics

FREE CASH FLOW (FCF)

$5.43B

FREE CASH FLOW (FCF) AVG TTM

$5.31B

FREE CASH FLOW (FCF) AVG 3Y

$5.10B

FREE CASH FLOW (FCF) AVG 5Y

$5.21B

FREE CASH FLOW (FCF) AVG 10Y

$5.14B

FREE CASH FLOW (FCF) AVG 15Y

$4.81B

FREE CASH FLOW (FCF) AVG 20Y

$4.27B

CURRENT VS TTM AVG

+2.27%

CURRENT VS 3Y AVG

+6.44%

CURRENT VS 5Y AVG

+4.17%

CURRENT VS 10Y AVG

+5.52%

CURRENT VS 15Y AVG

+12.85%

CURRENT VS 20Y AVG

+26.93%

FCF Analysis

Free Cash Flow (TTM)

$5.43B

FCF Yield

5.14%

Price/FCF

19.5

Formula: FCF = Operating Cash Flow - Capital Expenditures

Why FCF matters:

  • Shows actual cash available (not accounting earnings)
  • Funds dividends, buybacks, and debt reduction
  • Less susceptible to accounting manipulation than net income
  • Key metric for DCF valuation models

Medtronic plc Free Cash Flow (FCF) Formula & Definition

Free Cash Flow represents the cash a company generates after accounting for capital expenditures. It's the cash available for dividends, buybacks, debt reduction, or reinvestment.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Medtronic plc Free Cash Flow (FCF) FAQ

What is the free cash flow (FCF) for Medtronic plc (MDT)?
The free cash flow (FCF) for MDT stock is $5.43B.
What is the TTM average free cash flow (FCF) for Medtronic plc (MDT)?
The TTM average free cash flow (FCF) for MDT stock is $5.31B.
What is the 3Y average free cash flow (FCF) for Medtronic plc (MDT)?
The 3Y average free cash flow (FCF) for MDT stock is $5.10B.
What is the 5Y average free cash flow (FCF) for Medtronic plc (MDT)?
The 5Y average free cash flow (FCF) for MDT stock is $5.21B.
What is the 10Y average free cash flow (FCF) for Medtronic plc (MDT)?
The 10Y average free cash flow (FCF) for MDT stock is $5.14B.
What is the 15Y average free cash flow (FCF) for Medtronic plc (MDT)?
The 15Y average free cash flow (FCF) for MDT stock is $4.81B.
What is the 20Y average free cash flow (FCF) for Medtronic plc (MDT)?
The 20Y average free cash flow (FCF) for MDT stock is $4.27B.

Medtronic plc Free Cash Flow (FCF) History

DATEFREE CASH FLOW (FCF)
2026-04-24$5.43B
2025-04-30$5.18B
2024-04-30$5.20B
2023-04-30$4.58B
2022-04-30$5.98B
2021-04-30$4.88B
2020-04-30$6.02B
2019-04-30$5.87B
2018-04-30$3.62B
2017-04-30$5.63B
2016-04-30$4.17B
2015-04-30$4.33B
2014-04-30$4.56B
2013-04-30$4.43B
2012-04-30$3.85B
2011-04-30$3.19B
2010-04-30$3.50B
2009-04-30$3.21B
2008-04-30$2.88B
2007-04-30$2.29B
2006-04-30$963.20M
2005-04-30$2.37B
2004-04-30$2.42B
2003-04-30$1.70B
2002-04-30$1.20B
2001-04-30$1.39B
2000-04-30$699.90M
1999-04-30$-788.50M
1998-04-30$441.90M
1997-04-30$273.40M

About Medtronic plc

Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.

Galway
95,000 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Geoffrey Straub Martha